查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999309

兽医照护现场诊断市场：按动物种类、检测类型、技术、检体类型、应用和最终用户划分－2026-2032年全球市场预测

Veterinary Point Of Care Diagnostics Market by Animal Type, Test Type, Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，兽医即时诊断市场价值将达到 21.9 亿美元，到 2026 年将成长至 24.7 亿美元，到 2032 年将达到 51.3 亿美元，复合年增长率为 12.87%。

主要市场统计数据
基准年 2025 21.9亿美元
预计年份：2026年 24.7亿美元
预测年份 2032 51.3亿美元
复合年增长率 (%) 12.87%

简要介绍床边诊断和烧伤场诊断如何改变当今兽医学的提供和临床决策。

兽医领域的即时诊断正迅速从辅助工具转变为动物医疗保健服务的核心要素。兽医和畜牧管理者越来越需要在床边和畜舍内获得快速可靠的检测结果，以便即时做出临床决策、提高处理能力并减少因依赖中心检查室而造成的物流障碍。携带式检测化学技术、小型化分析仪和整合数位输出的进步缩短了检测结果的返回时间，使得在提供护理的当下即可获得有意义的诊断。

对重新定义兽医即时诊断和行业经营模式的关键技术、临床和商业性变革进行分析。

在兽医即时诊断领域，改变正在发生，重塑价值链、临床工作流程和投资重点。其中一个显着的变化是从一次性侧向流动检测装置转向更先进的、配备读卡器且无需导联的检测装置，从而实现定量输出、互联互通和结果标准化。这项转变将有助于与临床管理系统和远距分诊服务集成，使临床医生能够自信地做出数据驱动的决策，并将诊断范围扩展到远端和行动临床环境。

2025 年关税调整对兽医诊断设备和耗材的供应链、定价策略和采购选择的影响。

2025年实施的费用调整的累积影响对整个兽医诊断生态系统的筹资策略、定价机制和供应链韧性产生了显着影响。费用波动增加了进口分析仪器、核心模组和关键试剂的总进口成本，这些产品通常在高度专业化的海外工厂生产。对于利润空间较小的终端用户，例如行动诊所和小规模诊断检查室，这些增加的成本迫使他们调整服务价格并延长设备更新週期。

将动物物种、诊断方法、最终用户画像和检体处理途径与可操作的产品和渠道策略联繫起来的全面细分洞察。

从临床、技术和商业性等多个观点分析市场，可以揭示关键的市场区隔洞察。依动物种类划分，需求模式可分为伴侣动物和牲畜。在伴侣动物领域，由于饲主期望和临床症状的差异，猫和狗在诊断应用方面有明显差异。同时，在涵盖牛、马、家禽和猪的牲畜领域，加工能力、生物安全和批量检测流程往往是优先考虑的因素。这些不同的需求会影响检测套组的组成、分析仪器的处理能力和服务模式。

区域观点着重介绍全球主要地区的独特临床需求、监管细微差别和商业性路径。

区域趋势影响市场接受度曲线、监管路径和商业性优先事项，供应商和投资者在规划市场进入和扩张时必须考虑这些因素。在美洲，市场需求集中在先进的伴侣动物医疗和整合临床工作流程上，这得益于强大的私人兽医网络以及饲主对高端诊断的投资意愿。该地区的市场参与企业正着重强调设备性能、数位化整合和配套耗材，以此作为差异化优势，而基于远端医疗的诊断服务也呈现日益强劲的发展势头。

对成熟企业、专业兽医公司和创新Start-Ups如何竞争与合作，从而在设备、耗材和服务方面创造价值进行策略评估。

兽医照护现场诊断市场由众多成熟的诊断服务提供者、专业的兽医公司和灵活的Start-Ups组成，它们各自探索着不同的规模化发展路径。现有仪器製造商利用其成熟的分销网络和服务能力，向上提升销售整合的仪器和耗材解决方案；而专业的兽医公司则优先考虑临床有效性和与兽医工作流程相契合的产品设计。Start-Ups通常专注于高价值的单一应用、新型检测方法或能够简化结果解读和报告的数位化功能。

为供应商和投资者提供具体的策略建议，以加强兽医诊断领域的产品系列、供应链、服务模式和监管合规性。

产业领导企业可以透过实施一系列重点策略措施来加速市场渗透并确保可持续的竞争优势。首先，应优先考虑模组化产品架构。能够处理多种检测类型和检体基质的平台可以降低单位风险并提高生命週期效益。在保留用于定量和网路化工作流程的基于主控单元的产品线的同时，投资于低成本、高容量的无主控单元产品，可以扩大市场覆盖范围并提高定价柔软性。

对用于建立实用见解的主要和次要调查方法、专家检验流程和资料三角测量技术进行透明的概述。

本分析的调查方法结合了初步的质性研究和严谨的二次检验，以确保研究结果具有临床相关性和实践基础。初步研究包括对执业兽医、检查室主管、畜牧主管和产品开发经理进行结构化访谈，重点关注应用案例、采购决策标准以及对售后支援的期望。这些访谈揭示了产品接受度、工作流程整合以及现有诊断产品所面临的挑战等方面的真实情况。

一项决定性的整合，突显了技术、服务交付和营运韧性之间的相互作用，这决定了兽医诊断领域的长期成功。

总之，兽医照护现场诊断技术已进入成熟阶段，技术能力、服务设计和商业性弹性将决定其成败。携带式分子诊断工具、改进的免疫检测和数位化诊断平台的融合，为诊断技术从一次性应用转向伴侣动物诊所和畜牧场的常规应用铺平了道路。然而，要实现其持续普及，还需要考虑终端用户的经济负担、建立稳健的供应链，以及在不同动物物种和不同情况下证明其可衡量的临床效用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 兽医照护现场诊断市场：依动物类型划分

  • 伴侣动物
    • 猫
    • 狗
  • 家畜
    • 牛
    • 马
    • 家禽
    • 猪

第九章 兽医照护现场诊断市场：检测类型

  • 生物化学
    • 化学分析仪
    • 电解质分析仪
  • 血液学
    • 血球计数器
    • 血红素分析仪
  • 免疫检测
    • ELISA
    • 横向流动化验
  • 分子诊断

第十章 兽医照护现场诊断市场：依技术划分

  • 领导风格
  • 无领导

第十一章检体类型照护现场诊断市场

  • 血
  • 屎
  • 牛奶
  • 唾液
  • 尿

第十二章 兽医照护现场诊断市场：依应用领域划分

  • 心臟监测
  • 重症监护
  • 感染疾病
  • 代谢筛检

第十三章 兽医照护现场诊断市场：依最终用户划分

  • 诊断检查室
  • 医院和诊所
  • 研究机构

第十四章 兽医照护现场诊断市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 兽医照护现场诊断市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 兽医照护现场诊断市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国兽医照护现场诊断市场

第十八章：中国兽医照护现场诊断市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agrolabo Spa
  • B. Braun SE
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Dispomed Ltd.
  • Esaote SpA
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Heska Corporation by Mars Inc.
  • IDEXX Laboratories, Inc.
  • Medtronic PLC
  • Mindray Medical International Limited
  • Neogen Corporation
  • Nova Biomedical Corporation
  • Precision Biosensor Inc.
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac Corporation
  • Woodley Equipment Company Inc.
  • Zoetis Inc.
Product Code: MRR-3A2E844FD625

The Veterinary Point Of Care Diagnostics Market was valued at USD 2.19 billion in 2025 and is projected to grow to USD 2.47 billion in 2026, with a CAGR of 12.87%, reaching USD 5.13 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.19 billion
Estimated Year [2026] USD 2.47 billion
Forecast Year [2032] USD 5.13 billion
CAGR (%) 12.87%

A succinct introduction framing how bedside and barnside diagnostics are reshaping veterinary care delivery and clinical decision making today

Veterinary point-of-care diagnostics are rapidly transitioning from niche adjuncts to core elements of animal healthcare delivery. Vets and livestock managers increasingly demand fast, reliable test results at the bedside or barn to enable immediate clinical decisions, improve throughput, and reduce the logistical friction associated with centralized laboratories. Advances in portable assay chemistry, miniaturized analyzers, and integrated digital output have compressed turnaround times and allowed for meaningful diagnostics at the time and place of care.

This evolution is driven by several converging forces. Rising companion animal ownership and heightened willingness to invest in pet health are reshaping clinical expectations, while intensifying pressure to optimize herd health and biosecurity in livestock sectors is pushing farm managers to adopt more proactive diagnostic workflows. Concurrently, technological maturation across immunoassays, molecular platforms, and sensor technologies has enabled greater analytical performance in compact formats. Regulatory clarity in some jurisdictions and expanding training programs for veterinary professionals are reducing barriers to adoption.

Taken together, these dynamics are enabling practitioners to close the gap between clinical suspicion and verification, supporting earlier interventions, more targeted therapeutics, and measurable improvements in animal welfare and operational efficiency. The remainder of this executive summary examines the transformational shifts, segmentation nuances, regional differences, corporate responses, and strategic recommendations that leaders must weigh when engaging this dynamic market.

An analysis of the pivotal technological, clinical, and commercial shifts that are redefining point-of-care veterinary diagnostics and industry business models

The landscape of veterinary point-of-care diagnostics is undergoing transformative shifts that reconfigure value chains, clinical workflows, and investment priorities. One prominent change is the migration from single-use lateral flow devices toward more sophisticated reader-based and reader-less formats that enable quantitative outputs, connectivity, and result standardization. This shift supports integration with practice management systems and teletriage services, allowing clinicians to make data-driven decisions with confidence and to extend diagnostic reach into remote and ambulatory settings.

Simultaneously, molecular diagnostics are moving out of centralized labs and into near-patient environments, driven by simplified sample preparation, isothermal amplification methods, and cartridgeized consumables. The democratization of higher-sensitivity tests alters diagnostic pathways for infectious disease management in both companion animals and livestock, enabling faster containment and targeted therapeutics. Artificial intelligence and cloud analytics are adding a layer of interpretation to raw outputs, helping clinicians prioritize cases and identify epidemiological signals earlier.

As business models evolve, manufacturers and distributors are adopting service-centric approaches that bundle instruments with reagents, calibration services, and digital subscriptions to lock in lifetime value and improve predictability. These shifts are forcing legacy vendors to accelerate innovation cycles and newer entrants to demonstrate clinical validation, regulatory compliance, and cost-effective service operations. The aggregate result is a more connected, agile, and clinically impactful diagnostic ecosystem for animal health.

How the 2025 tariff adjustments reshaped supply chains, pricing strategies, and procurement choices across veterinary diagnostic equipment and consumables

The cumulative impact of tariff changes implemented in 2025 has materially influenced procurement strategies, pricing mechanisms, and supply chain resilience across the veterinary diagnostics ecosystem. Tariff dynamics have increased the landed cost of imported analyzers, reader modules, and critical reagent inputs that are often manufactured in highly specialized overseas facilities. For end users operating on tight margins, such as ambulatory clinics and small diagnostic laboratories, incremental cost increases create pressure to reprice services or lengthen replacement cycles for capital equipment.

Manufacturers and distributors responded by accelerating localization and dual-sourcing strategies. Some moved production of high-volume consumables to regional contract manufacturers, while others prioritized inventory hedging and multi-tier distribution to buffer short-term volatility. These maneuvers improved responsiveness but increased working capital requirements and added complexity to inventory management. In parallel, tariff-related cost pressures incentivized product redesigns that reduced reliance on tariffed components and optimized supply chains for modular assembly closer to major end-user markets.

From a market access viewpoint, tariff changes encouraged a sharper segmentation of value propositions. Vendors emphasized total cost of ownership, service reliability, and integrated consumables bundles to justify pricing in tariff-inflated environments. The net effect is a more defensive and strategically diversified industry posture, with opportunities for regional manufacturers to capture share where local production can undercut tariff-affected imports and for agile suppliers to offer differentiated service and subscription models that dampen immediate price sensitivity.

A comprehensive set of segmentation insights tying animal species, diagnostic modalities, end-user profiles, and sample pathways to actionable product and channel strategies

Key segmentation insights emerge when the market is examined through multiple lenses that reflect clinical, technological, and commercial realities. By animal type, demand patterns bifurcate between companion animals and livestock; within the companion segment, cats and dogs exhibit distinct diagnostic use cases driven by differences in caregiver expectations and clinical presentation, while livestock demands-spanning cattle, horses, poultry, and swine-tend to prioritize throughput, biosecurity, and batch testing workflows. These divergent needs affect kit formulation, analyzer throughput, and service models.

When tests are disaggregated by type, biochemistry solutions, which include chemistry analyzers and electrolyte analyzers, remain foundational for routine metabolic screening and critical care. Hematology instruments such as cell counters and hemoglobin analyzers are core to anemia workup and infection monitoring. Immunoassays continue to serve as rapid, easy-to-use screens delivered via ELISA formats or lateral flow assays, while molecular diagnostics provide higher sensitivity and specificity for pathogen detection in outbreak scenarios.

End users skew across diagnostic laboratories, hospitals and clinics, and research institutes, each with different procurement cycles, validation requirements, and budget horizons. Technology choices split between reader-based systems that deliver quantitation and connectivity, and reader-less formats that prioritize simplicity and low cost. Applications span cardiac monitoring, critical care, infectious disease detection, and metabolic screening, with sample types commonly including blood, feces, milk, saliva, and urine. Understanding how these segmentation axes intersect is central to product design and go-to-market prioritization because the optimal combination of analyzer capability, consumable format, and service offering varies significantly by animal type, test purpose, and care setting.

A regionally differentiated view highlighting the distinct clinical demands, regulatory nuances, and commercial pathways across major global territories

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in ways that vendors and investors must account for when planning market entry and expansion. In the Americas, demand is concentrated around advanced companion animal care and integrated clinic workflows, supported by strong private veterinary practice networks and a willingness among owners to invest in premium diagnostics. Market participants in this region emphasize instrument performance, digital integration, and bundled consumables as differentiators, and there is growing momentum for telehealth-enabled diagnostic services.

Across Europe, the Middle East & Africa, purchasers face a diverse landscape marked by high variability in regulatory frameworks, reimbursement norms, and veterinary service infrastructure. Western European markets trend toward clinical sophistication and regulation-driven validation requirements, while certain Middle Eastern and African markets prioritize ruggedness, cost efficiency, and simplified training models. These regional contrasts require tailored product lines and flexible commercial terms to accommodate heterogeneous procurement capabilities and clinical practices.

In the Asia-Pacific region, high population densities, expanding livestock operations, and rising companion animal ownership create strong demand for scalable diagnostics. Several markets show rapid adoption of mobile-enabled diagnostics and cloud analytics, and a robust local manufacturing base in some countries has supported faster rollout of cost-competitive consumables. Overall, regional strategies must balance global technology platforms with localized product adaptations, regulatory alignment, and distribution partnerships to achieve sustainable penetration.

A strategic assessment of how incumbents, specialized veterinary firms, and innovative startups are competing and collaborating to capture value across instruments, consumables, and services

The corporate landscape in veterinary point-of-care diagnostics is characterized by a blend of established diagnostics providers, specialized veterinary focused firms, and nimble startups, each pursuing different routes to scale. Incumbent device manufacturers leverage established distribution networks and service capabilities to upsell integrated instrument-and-consumable solutions, while specialized veterinary firms emphasize clinical validation and tailored product design to meet practitioner workflows. Startups frequently focus on single high-value applications, novel assay chemistries, or digital layers that simplify interpretation and reporting.

Strategic activity centers on partnerships, licensing, and co-development agreements that accelerate time to market while spreading development risk. Common approaches include collaborations with veterinary hospital groups to pilot new diagnostics, agreements with contract manufacturers to regionalize production, and alliances with software providers to embed connectivity and analytics into clinical routines. Competitive differentiation increasingly relies on the ability to deliver end-to-end value: reliable hardware, validated consumables, responsive service, and data tools that drive clinical utility.

Firms that secure long-term service contracts, optimize reagent logistics, and provide targeted clinician education programs tend to achieve higher retention and improved lifetime revenue. Conversely, companies that underinvest in local support or fail to demonstrate clear clinical advantages face protracted adoption cycles. For stakeholders evaluating partnerships, emphasis should be placed on operational readiness, quality systems, and the ability to support multi-species validation to maximize cross-segment applicability.

Actionable strategic recommendations for vendors and investors to strengthen product portfolios, supply chains, service models, and regulatory engagement in veterinary diagnostics

Industry leaders can accelerate adoption and secure durable advantage by implementing a focused set of strategic actions. First, prioritize product architectures that offer modularity: platforms capable of supporting multiple assay types and sample matrices reduce per-unit risk and increase life cycle revenues. Investing in reader-less formats for low-cost, high-volume use while maintaining reader-based offerings for quantitative and connected workflows enables broader market coverage and pricing flexibility.

Second, strengthen supply chain resilience through regional manufacturing partnerships and multilateral sourcing agreements that reduce exposure to tariff volatility and logistical disruption. Embedding local assembly and regional reagent production can shorten lead times and improve margin stability. Third, differentiate through service models that integrate training, calibration, and digital interpretive support; subscription-based consumable plans that include automatic replenishment and remote monitoring improve customer retention and stabilize revenue forecasts.

Fourth, engage proactively with regulators and key opinion leaders to accelerate clinical validation and create clear pathways for market access. Fifth, align commercial models to end-user economics by offering tiered instruments, bundled consumables, and flexible financing to accommodate varied budget profiles across veterinary clinics, diagnostic laboratories, and research institutes. Finally, embed data capabilities to convert diagnostic outputs into actionable practice intelligence and population health insights, thereby reinforcing the value proposition for buyers and payers alike.

A transparent outline of primary and secondary research approaches, expert validation processes, and data triangulation techniques used to build actionable intelligence

The research methodology underpinning this analysis combines primary qualitative inquiry with rigorous secondary validation to ensure findings are clinically relevant and operationally grounded. Primary research included structured interviews with practicing veterinarians, laboratory directors, livestock production managers, and product development leaders, focusing on use cases, procurement decision criteria, and post-purchase support expectations. These conversations provided real-world context for product acceptance, workflow integration, and pain points associated with existing diagnostic offerings.

Secondary research drew on technical literature, regulatory guidance documents, patents, and publicly available clinical validation studies to corroborate performance claims and identify technology trajectories. Data triangulation was employed to reconcile differing perspectives across stakeholder groups and to validate trends observed in practice. Segmentation analyses were performed by cross-referencing clinical use cases with instrumentation capabilities and consumables formats to determine where product fit aligns with end-user needs.

Limitations of the methodology include variability in regulatory transparency across regions and differing levels of adoption maturity across animal types, which can affect the generalizability of some tactical conclusions. To mitigate these constraints, findings were stress-tested through scenario analysis and subjected to peer review by independent industry experts, enhancing the robustness of the recommendations presented.

A conclusive synthesis emphasizing the interplay of technology, service delivery, and operational resilience that will determine long-term success in veterinary diagnostics

In conclusion, veterinary point-of-care diagnostics are entering a phase of practical maturation where technological capability, service design, and commercial agility determine winners and losers. The convergence of portable molecular tools, improved immunoassay formats, and digital interpretation platforms provides a clear pathway for diagnostics to move from episodic use toward routine integration in both companion animal clinics and livestock operations. However, sustained adoption depends on addressing end-user economics, building resilient supply chains, and demonstrating measurable clinical utility across multi-species contexts.

Organizations that combine modular product design with strong local support, intelligent service models, and partnerships that accelerate regulatory acceptance will be best positioned to capture durable value. Tariff pressures and regional variability underscore the need for flexible manufacturing footprints and adaptive commercial terms. Ultimately, the most compelling value propositions will be those that translate rapid, accurate diagnostics into improved clinical outcomes, reduced operational waste, and enhanced population health surveillance, thereby making point-of-care testing indispensable across animal health practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Point Of Care Diagnostics Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Cattle
    • 8.2.2. Horses
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Veterinary Point Of Care Diagnostics Market, by Test Type

  • 9.1. Biochemistry
    • 9.1.1. Chemistry Analyzer
    • 9.1.2. Electrolyte Analyzer
  • 9.2. Hematology
    • 9.2.1. Cell Counter
    • 9.2.2. Hemoglobin Analyzer
  • 9.3. Immunoassay
    • 9.3.1. Elisa
    • 9.3.2. Lateral Flow Assay
  • 9.4. Molecular Diagnostics

10. Veterinary Point Of Care Diagnostics Market, by Technology

  • 10.1. Reader Based
  • 10.2. Reader Less

11. Veterinary Point Of Care Diagnostics Market, by Sample Type

  • 11.1. Blood
  • 11.2. Feces
  • 11.3. Milk
  • 11.4. Saliva
  • 11.5. Urine

12. Veterinary Point Of Care Diagnostics Market, by Application

  • 12.1. Cardiac Monitoring
  • 12.2. Critical Care
  • 12.3. Infectious Disease
  • 12.4. Metabolic Screening

13. Veterinary Point Of Care Diagnostics Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Hospitals And Clinics
  • 13.3. Research Institutes

14. Veterinary Point Of Care Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Point Of Care Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Point Of Care Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Veterinary Point Of Care Diagnostics Market

18. China Veterinary Point Of Care Diagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agrolabo Spa
  • 19.6. B. Braun SE
  • 19.7. Biogal Galed Labs
  • 19.8. BioMerieux SA
  • 19.9. BioNote, Inc.
  • 19.10. Chembio Diagnostic Systems, Inc. by Biosynex
  • 19.11. Dispomed Ltd.
  • 19.12. Esaote SpA
  • 19.13. Fassisi GmbH
  • 19.14. FUJIFILM Holdings Corporation
  • 19.15. Heska Corporation by Mars Inc.
  • 19.16. IDEXX Laboratories, Inc.
  • 19.17. Medtronic PLC
  • 19.18. Mindray Medical International Limited
  • 19.19. Neogen Corporation
  • 19.20. Nova Biomedical Corporation
  • 19.21. Precision Biosensor Inc.
  • 19.22. Randox Laboratories Ltd.
  • 19.23. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 19.24. Thermo Fisher Scientific Inc.
  • 19.25. Vimian Group AB
  • 19.26. Virbac Corporation
  • 19.27. Woodley Equipment Company Inc.
  • 19.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CHEMISTRY ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CELL COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMOGLOBIN ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY READER LESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY FECES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY MILK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 223. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 259. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 271. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 273. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. NATO VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY BIOCHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES VETERINARY POINT OF CARE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED